Loading…
Stem Cell Research Enhancement Act of 2008
Legislative Progress
Introduced
September 26, 2008
Latest Action
September 26, 2008
Primary Sponsor
Diana DeGetteDemocratic(CO)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2008 · fourth_quarter · Medical/Disease Research/Clinical Labs
> pluripotent stem cell research, including S 5 and HR 7141 > Great Ape Protection Act: to ensure that necessary, lifesaving research can continue
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $131,467 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · fourth_quarter · Health Issues
H.R. 2762/S.1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians H.R. 7141, Stem Cell Research Enhancement Act of 2008
Client expense: $30,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Medical/Disease Research/Clinical Labs
The Stem Cell Research Enhancement Act, HR 7141
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Medical/Disease Research/Clinical Labs
> pluripotent stem cell research, including S 5 and HR 7141 > Great Ape Protction Act: to ensure that necessary, lifesaving research can continue > public access to NIH research results, including including provision in FY2008 omnibus appropriations, PL 110-161 > HR 7140 - Protection for Participants in Research Act
Client expense: $136,262 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2008 · third_quarter · Health Issues
H.R. 2762/ S. 1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 H.R. 7141, Stem Cell Research Enhancement Act of 2008
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2008 · third_quarter · Medical/Disease Research/Clinical Labs
Stem Cell Research Enhancement Act of 2008 HR 7141
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Medical/Disease Research/Clinical Labs
Stem cell research- funding and regulation; HR 7141, The Stem Cell Research Enhancement Act of 2008
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE